Retatrutide is an investigational triple-receptor agonist that activates GIP, GLP-1 and glucagon receptors
The sensation of body aches on this medication can vary in intensity and location
He is first and co-senior author of a new study recently published in the journal BMJ Open Diabetes Research & Care
Serious side effects could occur in rare cases, including pancreatitis or gallbladder problems
Subsequent drugs like liraglutide and semaglutide are engineered modifications of the human GLP-1 sequence, not lizard-derived
Branded FDA-approved alternatives (Ozempic, Wegovy, Mounjaro, Zepbound) are also available at manufacturer pricing, which typically runs $800 to $1,400 per month